Aziende Chimiche Riunite Angelini Francesco S.p.a

This study collects information from over 900 adults in Italy whose focal seizures are not controlled by at least two other seizure medicines. Researchers are tracking how well cenobamate reduces seizure frequency and how safe it is in everyday medical practice. The goal is to be…

This study follows 300 adults with focal onset seizures who are starting an additional anti-seizure medicine (ASM) alongside their current treatment. Researchers will track changes in seizure frequency and quality of life over 12 months in real-world conditions. The goal is to un…